Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
about
Heparin is Not Inferior to Bivalirudin in Percutaneous Coronary Intervention-Focusing on the Effect of Glycoprotein IIb/IIIa Inhibitor Use: A Meta-Analysis.Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.
P2860
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@ast
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@en
type
label
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@ast
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@en
prefLabel
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@ast
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@en
P2093
P1476
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
@en
P2093
Alessandro Lupi
Andrea Rognoni
Angelo S Bongo
Chiara Cavallino
Ettore Cassetti
Gioel G Secco
Maria D Prando
Matteo Santagostino
Maurizio Lazzero
P304
P356
10.2174/1871525711311020006
P577
2013-06-01T00:00:00Z